Empagliflozin Linagliptin
TRIJARDY XR is a combination of empagliflozin, linagliptin, and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .
United States
$584
per month
India
$19
per month
You save
−97%save $565/mo · 97% cheaper
136.7K US scripts/yr$77.2M potential annual savings$79.8M US spend/yr
Drag to rotate · 3D structureC23H27ClO7
SMILES: C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl
Compare the price
US price$584per month
India price$19per month
You save$56597% less
Based on 30 units per month. US $19.46 vs India $0.63 per unit.
Total over 1 periodSave $565$584 → $19
The bigger picture
Empagliflozin Linagliptin is filled about 136.7K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$79.8M
If sourced from India
$2.6M
Potential annual savings
$77.2M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.